Osteopore (ASX:OSX) FCF Margin % : -114.77% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Osteopore FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Osteopore's Free Cash Flow for the six months ended in Jun. 2024 was A$-1.69 Mil. Osteopore's Revenue for the six months ended in Jun. 2024 was A$1.48 Mil. Therefore, Osteopore's FCF Margin % for the quarter that ended in Jun. 2024 was -114.77%.

As of today, Osteopore's current FCF Yield % is -87.47%.

The historical rank and industry rank for Osteopore's FCF Margin % or its related term are showing as below:

ASX:OSX' s FCF Margin % Range Over the Past 10 Years
Min: -443.93 Med: -239.78 Max: -129.45
Current: -129.45

During the past 6 years, the highest FCF Margin % of Osteopore was -129.45%. The lowest was -443.93%. And the median was -239.78%.

ASX:OSX's FCF Margin % is ranked worse than
81.82% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -4.42 vs ASX:OSX: -129.45

Osteopore FCF Margin % Historical Data

The historical data trend for Osteopore's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osteopore FCF Margin % Chart

Osteopore Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-443.93

-142.13

-359.48

-239.78

-155.48

Osteopore Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Margin %	Get a 7-Day Free Trial					-266.54	-214.84	-195.39	-147.21	-114.77

Competitive Comparison of Osteopore's FCF Margin %

For the Medical Instruments & Supplies subindustry, Osteopore's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Osteopore's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Osteopore's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Osteopore's FCF Margin % falls into.

Osteopore FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Osteopore's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3.744	/	2.408
	=	-155.48 %

Osteopore's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-1.694	/	1.476
	=	-114.77 %

Osteopore FCF Margin % Related Terms

Thank you for viewing the detailed overview of Osteopore's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Osteopore Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osteopore Ltd (ASX:OSX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

191 Street Georges Terrace, Level 5, Perth, WA, AUS, 6000

Website

https://www.osteopore.com

Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.

Osteopore Headlines

No Headlines